2021
DOI: 10.22159/ijap.2021.v13s4.43860
|View full text |Cite
|
Sign up to set email alerts
|

The Molecular Interaction and Admet Prediction of Modified Jph203 as a Potential Radiopharmaceutical Kit for Molecular Imaging of Cancer: An in Silico Research

Abstract: Objective: In this study, various types of pharmacokinetic modifying linkers and chelators are combined with JPH203 to obtain the best-docked molecule for prospective radiopharmaceutical kits. Methods: AutoDock 4.2.6 and AutoDockTools 1.5.6 programs was used to do the molecular docking simulation and ADMET prediction was done using VNN-ADMET to predict the pharmacokinetics and toxicity of the ligand. Results: The result of this study showed that JPH203-linker K-NOTA has the best affinity with a doc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 11 publications
0
3
0
Order By: Relevance
“…Meanwhile, the lowest binding affinity (∆G) was-5.91 kcal/mol, and the inhibition constant (Ki) was 46.27 nM at run 51. This study has a ∆G that is better than the research [23], which is 5.65 kcal/mol, with (Ki) 72.72 nM.…”
Section: Discussionmentioning
confidence: 53%
See 1 more Smart Citation
“…Meanwhile, the lowest binding affinity (∆G) was-5.91 kcal/mol, and the inhibition constant (Ki) was 46.27 nM at run 51. This study has a ∆G that is better than the research [23], which is 5.65 kcal/mol, with (Ki) 72.72 nM.…”
Section: Discussionmentioning
confidence: 53%
“…The redocking results from this study have an RMSD greater than the research [12] is 0.45. Validity of the molecular docking approach is achieved when the RMSD value is ≤2.0 Å [23]. Meanwhile, the lowest binding affinity (∆G) was-5.91 kcal/mol, and the inhibition constant (Ki) was 46.27 nM at run 51.…”
Section: Discussionmentioning
confidence: 99%
“…COX-1 binding validation was carried out with its natural ligand, ibuprofen, and for the validation of the binding of the COX-2 enzyme, the crystalline, which was Celecoxib. Was isolated, and validation was carried out for binding site analysis to see an interaction between each natural ligand against the enzyme receptor and to determine the amino acid residues of the iNOS, COX-1, and COX-2 enzyme binding pockets [16].…”
Section: Docking Validation Methodsmentioning
confidence: 99%